Basic info
Industry
pharmaceutical manufacturing
Sectors
NSF
Biotechnology
Acute Kidney Injury
MRI
Oncology
Chronic Kidney Disease
Contrast Induced Nephropathy
Pharmaceutical
Orphan drug
Health Care
Contrast Media
Radiology
Medical
Drugdevelopment
Date founded
2000
Funding rounds raised
Total raised
$24M
from 2 investors over 2 rounds
A
Ascelia Pharma AB raised $24M on March 17, 2021
Investors: HealthInvest Partners and Sunstone Life Science Ventures